Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2008 December;60(4) > Minerva Urologica e Nefrologica 2008 December;60(4):255-64

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA UROLOGICA E NEFROLOGICA

A Journal on Nephrology and Urology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,536


eTOC

 

REVIEWS  


Minerva Urologica e Nefrologica 2008 December;60(4):255-64

language: English

Management of bladder cancer

Hegarty P. K., Kamat A. M.

Department of Urologic Oncology M. D. Anderson Cancer Center at the University of Texas, Houston, TX, USA


PDF  


Bladder cancer is the fourth most common cancer in men and is increasing in incidence in women as well. Bladder cancer has a broad range of behavior and presentations, with different prognoses and treatments. Laboratory research has made strides in elucidating pathways of this cancer, and identifying novel therapeutic targets. This short review provides a summary of the current knowledge of the management of bladder cancer.

top of page

Publication History

Cite this article as

Corresponding author e-mail